CD79A and infection: Screening neonatal cord blood for SARS-CoV-2 specific IgA along with IgG and IgM antibodies can be a reliable strategy to identify newborns with serological markers of potential in utero infection so that they can be followed more closely and evaluated over time for infant outcomes.